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Background
Despite the widespread use of CHO cells for the produc-
tion of many industrially relevant biopharmaceuticals,
this system is poorly understood on the genetic level and
mainly relies on empirical procedures, due to the lack of
adequate sequence information. In order to advance its
overall performance, we successfully tested the applicabil-
ity of a cross-species microarray approach, for investigat-
ing CHO specific transcription profiles [1]. In the present
study we show expression signatures of individual recom-
binant CHO clones which correlate with their associated
phenotype.
Results
Clones were cultivated in repeated batch mode (5
batches) in Sixfors bioreactors. Several CHO model clones
were analyzed on an Agilent genomics platform using 60-
mer oligonucleotide mouse microarrays. We could detect
distinctive target genes between different model clones,
all characterized by high production levels of the recom-
binant protein. What we also found were commonly
enriched Gene Ontology (GO) categories present in all
the clones with this particular property. In addition, a
group of similar clones with improved sialylation capabil-
ities was studied, since the protein used in these experi-
ments is heavily glycosilated, and found to share common
signature genes and enriched GO terms. In a further
model we tried to identify predictive genes for stress sus-
ceptibility under bioreactor conditions. We compared a
resistant and a susceptible clone in spinner cultures and
during bioreactor cultivation. There was a striking similar-
ity both in the expression profile and the level of expres-
sion when early and late growth stages of this clone were
compared. Hence, these prognostic signatures could be
used as a selection tool and further help to understand
some of the factors involved in stress response under
altered growth conditions.
Conclusion
Transcriptome analysis has the potential to efficiently
identify parameters for cell line improvement. In particu-
lar, cross-species analysis can be a useful tool to study
gene expression profiles of related organisms for which
species-specific microarrays are not available. The signa-
ture genes we were able to detect correlated with the phe-
notypic properties of the investigated clones, like high
production levels, improved capabilities of product gly-
cosilation, and stress resistance under bioreactor growth
conditions. This knowledge could be helpful in under-
standing cellular mechanisms and could further serve to
develop a robust host cell line for effective process per-
formance.
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